Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding CERE, Q2 2024
1 superinvestor reports holding Cerevel Therapeutics Holdings, Inc. on Form 13F, worth $88.0M in total. Weight is Cerevel Therapeutics Holdings, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2024.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 2.0% | 2,151,641 | $88.0M | Added+10.9% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CERE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+10.9%)
Q1 2024
1 superinvestor holding at quarter end